Free Trial

Quoin Pharmaceuticals (QNRX) SEC Filings & 10K Form

Quoin Pharmaceuticals logo
$8.32 -0.15 (-1.71%)
As of 10:30 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Quoin Pharmaceuticals SEC Filings

DateFilerForm TypeView
06/04/2025
3:00 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/02/2025
7:42 PM
Myers Michael (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
7:36 PM
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
SEMBER MICHAEL T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
7:37 PM
Cooper Joseph Patrick (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
7:38 PM
LANGER DENNIS (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
7:39 PM
Leong Natalie Ee Mun (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2025
7:40 PM
Carter Denise P. (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
7:31 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/04/2025
7:30 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/03/2025
11:15 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form EFFECT
03/28/2025
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form POS AM
03/20/2025
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/04/2025
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/28/2025
3:43 PM
Carter Denise P. (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/28/2025
3:44 PM
Myers Michael (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SCHEDULE 13D/A
01/23/2025
3:15 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/16/2025
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
3:34 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2025
4:20 PM
Myers Michael (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SCHEDULE 13D
01/02/2025
4:20 PM
Carter Denise P. (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SCHEDULE 13D
12/27/2024
4:15 PM
Culverwell Anthony James (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
4:16 PM
Dunn Gordon (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
4:16 PM
Myers Michael (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
4:17 PM
Carter Denise P. (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
8:00 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/23/2024
8:01 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 424B4
12/22/2024
11:15 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form EFFECT
12/19/2024
8:00 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/18/2024
3:01 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form S-1/A
12/11/2024
3:20 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form S-1
Registration statement under Securities Act of 1933  
12/11/2024
5:01 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 424B3
12/10/2024
3:45 PM
LANGER DENNIS (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:46 PM
Leong Natalie Ee Mun (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:47 PM
Myers Michael (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:47 PM
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
SEMBER MICHAEL T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:49 PM
Carter Denise P. (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:50 PM
Culverwell Anthony James (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:51 PM
Dunn Gordon (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:52 PM
Cooper Joseph Patrick (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/10/2024
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
6:23 PM
Lind Global Fund II LP (Filed by)
Quoin Pharmaceuticals, Ltd. (Subject)
Quoin Pharmaceuticals (Subject)
Form SC 13G/A
Trump wipes out trillions overnight… (Ad)

Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.

Whether you take some of that wealth for yourself depends on if you watch this controversial exposé
11/08/2024
4:04 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 424B3
10/31/2024
3:30 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
5:15 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form ARS
10/24/2024
5:15 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form DEF 14A
10/11/2024
3:56 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form PRE 14A
09/30/2024
5:07 AM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
3:30 PM
Dunn Gordon (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
11:03 AM
Myers Michael (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/05/2024
11:06 AM
Carter Denise P. (Reporting)
Quoin Pharmaceuticals, Ltd. (Issuer)
Quoin Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:32 PM
Quoin Pharmaceuticals, Ltd. (Filer)
Quoin Pharmaceuticals (Filer)
Form 424B3
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:QNRX) was last updated on 6/13/2025 by MarketBeat.com Staff
From Our Partners